Glucotrack, Inc. Files 8-K: Material Agreement & Exhibits
Ticker: GCTK · Form: 8-K · Filed: Dec 17, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Dec 17, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $8.23 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, exhibits
TL;DR
Glucotrack (GCTK) filed an 8-K on Dec 17, 2024, for a material definitive agreement and exhibits.
AI Summary
On December 17, 2024, Glucotrack, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.
Why It Matters
This filing signals a significant development for Glucotrack, Inc., potentially involving a new contract or partnership that could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could represent a significant positive or negative development for the company, warranting further investigation.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- December 17, 2024 (date) — Date of earliest event reported
- Integrity Applications, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Rutherford, NJ (location) — Principal executive offices address
FAQ
What is the nature of the material definitive agreement entered into by Glucotrack, Inc. on December 17, 2024?
The filing states an 'Entry into a Material Definitive Agreement' as an item information, but the specific details of the agreement are not provided in this excerpt.
What financial statements and exhibits are included in this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific content of these documents is not detailed in this excerpt.
When was Glucotrack, Inc. formerly known as Integrity Applications, Inc. and when did its name change?
The company was formerly known as Integrity Applications, Inc. with a date of name change on 20101203, and also formerly known as GlucoTrack, Inc. with a date of name change on 20220328.
What is Glucotrack, Inc.'s SIC code and industry classification?
Glucotrack, Inc. has a Standard Industrial Classification (SIC) code of 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
Where are Glucotrack, Inc.'s principal executive offices located?
Glucotrack, Inc.'s principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.
Filing Stats: 959 words · 4 min read · ~3 pages · Grade level 11.7 · Accepted 2024-12-17 17:27:33
Key Financial Figures
- $0.001 — ) shares of the Company's common stock, $0.001 par value per share (the "Common Stock"
- $8.23 m — ng an aggregate offering price of up to $8.23 million, from time to time, through an "a
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex1-1.htm (EX-1.1) — 273KB
- ex5-1.htm (EX-5.1) — 15KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-050462.txt ( ) — 575KB
- gctk-20241217.xsd (EX-101.SCH) — 3KB
- gctk-20241217_lab.xml (EX-101.LAB) — 33KB
- gctk-20241217_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. 1.1 At-the-Market Sales Agreement, dated December 17, 2024, by and between Glucotrack, Inc. and Dawson James Securities, Inc. 5.1 Opinion of Nelson Mullins Riley & Scarborough LLP. 23.1 Consent of Nelson Mullins Riley & Scarborough LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 17, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer